Delivery Order SPE2DR25D2206-SPE2DR26F9KL4
- Not listed
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 120 capsules of Tafinlar 75 mg, a chemotherapy medication, under a firm fixed-price contract valued at $54,926.66. The contract was competitively awarded without set-aside provisions and is scheduled for completion by October 9, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a $8,896.41 delivery order to AmerisourceBergen Drug Corp for Tafinlar 75 mg capsules (120 count) on July 17, 2025, with an ultimate completion date of August 7, 2025. This firm fixed price delivery order, issued without set-aside designation, was competitively awarded and performed at the contractor's Conshohocken, Pennsylvania location. The award represents a single shipment of this oncology medication through AmerisourceBergen's established federal...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Tafinlar 75 mg capsules (120-count units) under a firm fixed-price contract. The award, valued at $17,792.82, is set to be completed by September 12, 2025, and represents a non-set-aside competitive award. AmerisourceBergen will perform fulfillment from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major...
- The Defense Logistics Agency awarded a $9.38K delivery order to AmerisourceBergen Drug Corp on December 22, 2025, for the supply of Tafinlar 75 mg capsules (120-count units). This is a firm fixed-price delivery order with no set-aside designation, representing a competitive award under the company's existing contract vehicle. The order is scheduled for completion by January 14, 2026, with performance at AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Tafinlar 50 mg capsules (120-count units) with a ceiling value of $13,836.26. This firm fixed-price delivery order, with an ultimate completion date of September 24, 2025, represents a competitively awarded, non-set-aside contract with no small business preferences applied. The work is being performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tafinlar 75 mg capsules (120-count units) under a firm fixed-price contract valued at $8,896.41. The award was issued on August 5, 2025, with an ultimate completion date of August 26, 2025. This non-set-aside competitive award represents a continuation of AmerisourceBergen's critical role as a pharmaceutical distributor supporting federal medical procurement needs, particularly for...
- The Defense Logistics Agency awarded a $37,501.80 delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of TAFINLAR 75 mg capsules (120-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of November 21, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $20,754.39 to AmerisourceBergen Drug Corp for the supply of Tafinlar 50 mg capsules (120 count) on September 22, 2025, with completion scheduled for October 14, 2025. This competitively awarded, firm fixed-price delivery order represents a pediatric pharmaceutical product delivery under a non-set-aside procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp valued at $9.4K for the supply of Tafinlar 75 mg capsules (120-count units) under a firm fixed-price contract. This non-set-aside delivery order was awarded on November 28, 2025, with an ultimate completion date of December 19, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 21, 2025, for the supply of Tafinlar 75 mg capsules (120 count) with a ceiling value of $8,896.41. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to support federal medical procurement needs. The order is scheduled for completion by September 12, 2025, and will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery...
- SPE2DR25D2206Indefinite Delivery Contract
- SPE2DR25D2206-SPE2DR26F9KL4Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $16,023.16 to AmerisourceBergen Drug Corp for 120 capsules of Tafinlar 50 mg, a chemotherapy medication used in cancer treatment. This non-competitive delivery order was issued on January 9, 2026, with an ultimate completion date of February 2, 2026, and represents a firm fixed-price purchase under the company's existing contract vehicle with DLA. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031. This comprehensive IDC enables the company to supply a broad range of pharmaceutical products and medical supplies—including specialty medications, brand-name and generic drugs, vaccines, and medical devices—to support military healthcare programs globally. The contract supports various federal healthcare systems including the Defense Health Agency and U.S. Coast Guard, demonstrating AmerisourceBergen's role as a critical pharmaceutical supplier within the federal medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.0k | 1/8/26 |